Monopar Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Option
ANDERSON RAYMOND director
Common Stock 751 N/A N/A
Option
STARR CHRISTOPHER M director
Common Stock 751 N/A N/A
Option
KLAUSNER ARTHUR J director
Restricted Stock Units 751 N/A N/A
Option
STARR CHRISTOPHER M director
Restricted Stock Units 751 N/A N/A
Option
ANDERSON RAYMOND director
Restricted Stock Units 751 N/A N/A
Sale
TACTIC PHARMA LLC 10 percent owner
Common stock 125,000 $15.17 $1,896,250
Sale
TACTIC PHARMA LLC 10 percent owner
Common stock 125,000 $15.17 $1,896,250
Sale
TACTIC PHARMA LLC 10 percent owner
Common stock 125,000 N/A N/A
Option
ROBINSON CHANDLER director, officer: Chief Execut..
Restricted Stock Units 6,724 N/A N/A
Option
MAZAR ANDREW PAUL director, officer: Chief Scient..
Restricted Stock Units 1,937 N/A N/A
Option
MAZAR ANDREW PAUL director, officer: Chief Scient..
Common Stock 1,937 N/A N/A
Option
ROBINSON CHANDLER director, officer: Chief Execut..
Common Stock 6,724 N/A N/A
Option
TSUCHIMOTO KIM R officer: Chief Financial Officer
Restricted Stock Unit 1,231 N/A N/A
Option
TSUCHIMOTO KIM R officer: Chief Financial Officer
Common Stock 1,231 N/A N/A
Option
ANDERSON RAYMOND director
Common Stock 322 N/A N/A
Option
KLAUSNER ARTHUR J director
Common Stock 322 N/A N/A
Option
ANDERSON RAYMOND director
Restricted Stock Units 322 N/A N/A
Option
KLAUSNER ARTHUR J director
Restricted Stock Units 322 N/A N/A
Option
STARR CHRISTOPHER M director
Common Stock 322 N/A N/A
Option
STARR CHRISTOPHER M director
Restricted Stock Units 322 N/A N/A
Option
BROWN MICHAEL J director
Restricted Stock Units 322 N/A N/A
Option
BROWN MICHAEL J director
Common Stock 322 N/A N/A
Option
BROWN MICHAEL J director
Restricted Stock Units 322 N/A N/A
Option
KLAUSNER ARTHUR J director
Common Stock 322 N/A N/A
Option
KLAUSNER ARTHUR J director
Restricted Stock Units 322 N/A N/A
Option
STARR CHRISTOPHER M director
Common Stock 322 N/A N/A
Option
ANDERSON RAYMOND director
Common Stock 322 N/A N/A
Option
BROWN MICHAEL J director
Common Stock 322 N/A N/A
Option
ANDERSON RAYMOND director
Restricted Stock Units 322 N/A N/A
Option
STARR CHRISTOPHER M director
Restricted Stock Units 322 N/A N/A
Option
STARR CHRISTOPHER M director
Common Stock 323 N/A N/A
Option
STARR CHRISTOPHER M director
Restricted Stock Units 323 N/A N/A
Option
BROWN MICHAEL J director
Common Stock 323 N/A N/A
Option
ANDERSON RAYMOND director
Common Stock 323 N/A N/A
Option
ANDERSON RAYMOND director
Restricted Stock Units 323 N/A N/A
Option
BROWN MICHAEL J director
Restricted Stock Units 323 N/A N/A
Option
KLAUSNER ARTHUR J director
Restricted Stock Units 323 N/A N/A
Option
KLAUSNER ARTHUR J director
Common Stock 323 N/A N/A
Option
BROWN MICHAEL J director
Common Stock 322 N/A N/A
Option
BROWN MICHAEL J director
Restricted Stock Units 322 N/A N/A
Option
STARR CHRISTOPHER M director
Common Stock 322 N/A N/A
Option
ANDERSON RAYMOND director
Common Stock 322 N/A N/A
Option
STARR CHRISTOPHER M director
Restricted Stock Units 322 N/A N/A
Option
KLAUSNER ARTHUR J director
Common Stock 322 N/A N/A
Option
KLAUSNER ARTHUR J director
Restricted Stock Units 322 N/A N/A
Option
ANDERSON RAYMOND director
Restricted Stock Units 322 N/A N/A
Purchase
LEO KARL 10 percent owner
Common stock 156,563 $8 $1,252,504
Purchase
HENDRICKS DIANE 10 percent owner
Common stock 468,750 $8 $3,750,000
Purchase
TACTIC PHARMA LLC 10 percent owner
Common stock 125,000 $8 $1,000,000
Purchase
TSUCHIMOTO KIM R officer: Chief Financial Officer
Common stock 325 $8 $2,600

Showing 200 to 250 of 252 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.